Novel coating for stents could lower odds of blood clotting

09/9/2013 | PhysiciansBriefing.com

A study in Arteriosclerosis, Thrombosis, and Vascular Biology found that coating stents with CTP synthase 1 inhibitors such as cyclopentenyl cytosine may help inhibit smooth muscle cell proliferation, potentially cutting the risk of blood clots. "Our study identified CTPS1 as a novel target for developing anti-neointima drugs that are SMC-sensitive but have little side-effect on re-endothelialization during vascular repair," researchers said.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT